Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
3
×
clinical trials
life sciences
national blog main
national top stories
third rock ventures
3
×
cancer drugs
ipo
revolution medicines
san francisco
san francisco blog main
san francisco top stories
sanofi
the column group
warp drive bio
adeno-associated virus
amgen
boston
chemotherapy
cisplatin
cobimetinib
colorectal cancer
deals
decibel therapeutics
gene therapy
hearing loss
investing
joe burns
laurence reid
mark goldsmith
new york blog main
non-small cell lung cancer
pancreatic cancer
ras
regenerative medicine
regeneron pharmaceuticals
roche
What
medicines
3
×
cancer
ipo
proteins
research
revolution
adding
ago
aiming
balance
build
cancer’s
decibel
despite
disease
drug
drugs
emerged
family
focus
forms
frontiers
hardest
hearing
hit
hottest
hunters
known
loss
maps
med
parlance
pharmaceutical
pipeline
play
ras
reach
reels
regenerative
revealed
Language
unset
Current search:
medicines
×
cancer
×
" third rock ventures "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers